News
kmk-vova/iStock via Getty Images The US FDA has approved AbbVie’s Skyrizi (risankizumab) for use in children six years and older with moderate-to-severe plaque psoriasis or…
It one of the worst weeks for tech stocks of…
Tech rout drags S&P 500 to weekly decline
Even in a White House viewed as business friendly, a United and American combo would…
Chicago Fed’s Goolsbee: Inflation shocks from the energy markets crisis will delay interest rates in…
“My brothers and I are willing to split the cost of life insurance for her,…
Dollar share falls to 45%—are Bitcoin, gold the silent reserve rivals?
It didn’t happen right away this time, but investors who held through March’s market tumult…
NRG Energy announces secured and unsecured notes offerings

